FDA Requires Expanded Labeling About Weight Loss Risk in Patients Younger
Weight Loss Risk – In a significant move aimed at enhancing drug safety, the U.S. Food and Drug Administration (FDA) has mandated expanded labeling for certain weight loss medications, particularly those prescribed to younger populations.
